Scisparc Ltd (SPRC)

Currency in USD
5.670000
-0.050000(-0.87%)
Closed·
After Hours
5.790000+0.120000(+2.12%)
·
SPRC Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SPRC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.3501005.850000
52 wk Range
4.13700037.590000
Key Statistics
Prev. Close
5.72
Open
5.72
Day's Range
5.3501-5.85
52 wk Range
4.137-37.59
Volume
29.24K
Average Volume (3m)
110K
1-Year Change
-34.67%
Book Value / Share
47.75
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SPRC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Scisparc Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Scisparc Ltd Company Profile

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer’s disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. It also sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110, palmitoylethanolamide oral tablets and CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer’s to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer’s disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

Employees
2

Compare SPRC to Peers and Sector

Metrics to compare
SPRC
Peers
Sector
Relationship
P/E Ratio
−0.5x−1.4x−0.5x
PEG Ratio
−0.010.000.00
Price/Book
0.4x0.3x2.6x
Price / LTM Sales
2.3x0.9x3.2x
Upside (Analyst Target)
-39.5%45.7%
Fair Value Upside
Unlock26.4%8.6%Unlock

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
-6.20 / --
Revenue / Forecast
466.00K / --
EPS Revisions
Last 90 days

SPRC Income Statement

People Also Watch

131.10
ALAB
-4.12%
3.800
GNLN
-4.52%
9.7200
CYCC
-13.29%
16.380
QBTS
-4.71%
0.039
NCNA
-9.32%

FAQ

What Stock Exchange Does Scisparc Trade On?

Scisparc is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Scisparc?

The stock symbol for Scisparc is "SPRC."

What Is the Scisparc Market Cap?

As of today, Scisparc market cap is 3.03M.

What Is Scisparc's Earnings Per Share (TTM)?

The Scisparc EPS (TTM) is -22.65.

From a Technical Analysis Perspective, Is SPRC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Scisparc Stock Split?

Scisparc has split 2 times.

How Many Employees Does Scisparc Have?

Scisparc has 2 employees.

What is the current trading status of Scisparc (SPRC)?

As of 02 Aug 2025, Scisparc (SPRC) is trading at a price of 5.67, with a previous close of 5.72. The stock has fluctuated within a day range of 5.35 to 5.85, while its 52-week range spans from 4.14 to 37.59.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.